This page contains summaries of decisions made by the NENC NENC Clinical Effectiveness and Governance (CEG) Subcommittee and its subgroups. Summaries are published following each meeting of the NENC Clinical Effectiveness and Governance (CEG) Subcommittee.

Title Documents Decision Date

New

27/07/2026
Guidelines Decision Summary July 2026 Medicines guidelines approved by CEG for publication July 2026 - for NTAG website Approved 23/07/2026

New

27/07/2026
Medicines Decision Summary July 2026 Medicines recommendations approved by CEG for publication - July 2026 - for NTAG website Approved 23/07/2026
Guidelines Decision Summary May 2026 Medicines guidelines approved by CEG for publication May 2026 - for NTAG website Approved 04/06/2026
Medicines Decision Summary May 2026 Medicines recommendations approved by CEG for publication - May 2026 - for NTAG website Approved 04/06/2026
Guidelines Decision Summary March 2026 Medicines guidelines approved by CEG for publication March 2026 Approved 26/03/2026
Medicines Decision Summary March 2026 Medicines recommendations approved by CEG for publication - March 2026 Approved 26/03/2026
Guidelines Decision Summary February 2026 Medicines guidelines approved by CEG for publication February 2026 Approved 26/02/2026
Guidelines Decision Summary January 2026 Medicines guidelines approved by CEG for publication January 2026 Approved 22/01/2026
Medicines Decision Summary January 2026 Medicines recommendations approved by CEG for publication - January 2026 Approved 22/01/2026
Guidelines Decision Summary December 2025 Medicines guidelines approved by CEG for publication December 2025 Approved 11/12/2025
Medicines Decision Summary December 2025 Medicines recommendations approved by CEG for publication - December 2025 Approved 11/12/2025
Guidelines Decision Summary October 2025 Medicines guidelines approved by CEG for publication October 2025 Approved 09/10/2025
Medicines Decision Summary - 30-day NICE TA1094 and TA1095- August 2025 Medicines Decision Summary - 30-day NICE TA1094 and TA1095- August 2025 Approved 09/10/2025
Medicines Decision Summary October 2025 Medicines recommendations approved by CEG for publication - October 2025 Approved 09/10/2025
Guidelines Decision Summary August 2025 Medicines guidelines approved by CEG for publication August 2025 Approved 14/08/2025
Medicines Decision Summary August 2025 Medicines recommendations approved by CEG for publication - August 2025 Approved 14/08/2025
Medicines Decision Summary - 30-day NICE TA1085 - July 2025 Medicines Decision Summary - 30-day NICE TA1085 - July 2025 Approved 11/09/2025
Medicines Decision Summary - 30-day NICE TA1080 - July 2025 Medicines Decision Summary - 30-day NICE TA1080 - July 2025 Approved 11/09/2025
Medicines Decision Summary - 30-day NICE TA1075- July 2025 Medicines Decision Summary - 30-day NICE TA1075 - July 2025 Approved 14/08/2025
Medicines Decision Summary - 30-day NICE TA1066 - June 2025 Medicines Decision Summary - 30-day NICE TA1066 - June 2025 Approved 10/07/2025
Guidelines Decision Summary June 2025 Medicines guidelines approved by CEG for publication June 2025 Approved 12/06/2025
Medicines Decision Summary June 2025 Medicines recommendations approved by CEG for publication - June 2025 - final Approved 12/06/2025
Guidelines Decision Summary April 2025 Medicines guidelines approved by CEG for publication April 2025 Approved 10/04/2025
Medicines Decision Summary April 2025 Medicines recommendations approved by CEG for publication - April 2025 Approved 10/04/2025
Guidelines Decision Summary February 2025 Medicines guidelines approved by CEG for publication Feb 2025 Approved 13/02/2025
Medicines Decision Summary February 2025 Medicines recommendations approved by CEG for publication - February 2025 Approved 13/02/2025
Guidelines Decision Summary December 2024 Medicines guidelines approved by CEG for publication Dec 2024 Approved 12/12/2024
Medicines Decision Summary December 2024 Medicines recommendations approved by CEG for publication - December 24 Approved 12/12/2024
Medicines Decision Summary - 30-day NICE TA1004 - October 2024 Medicines Decision Summary - 30-day NICE TA1004 - October 2024 Approved 14/10/2024
Medicines Decision Summary October 2024 Medicines recommendations approved by CEG for publication Oct 24 - amended 4.11.24 Approved 10/10/2024
Guidelines Decision Summary October 2024 Medicines guidelines approved by CEG for publication Oct 24 Approved 10/10/2024
Medicines Decision Summary - 30-day NICE TA999 - September 2024 Medicines Decision Summary - 30-day NICE TA999 - September 2024 Approved 20/09/2024
Medicines Decision Summary - 30-day NICE TA998 - August 2024 Medicines Decision Summary - 30-day NICE TA998 - August 2024 Approved 16/09/2024
Medicines Subcommittee decision summary August 2024 NENC Medicines Committee decision summary - August 2024 - final Approved 16/09/2024
Medicines Decision Summary - 30-day NICE TA990 - July 2024 Medicines Decision Summary - 30-day NICE TA990 - July 2024 Approved 03/09/2024
Medicines Subcommittee decision summary June 2024 NENC Medicines Committee decision summary - June 2024 - final Approved 10/06/2024
Medicines Decision Summary - 30-day NICE TA971 - May 2024 Medicines Decision Summary - 30-day NICE TA971 - June 2024 Approved 06/06/2024
Medicines Subcommittee decision summary April 2024 NENC Medicines Committee decision summary - April 2024 v2 Approved 08/04/2024
Medicines Decision Summary - 30-day NICE TA953 - March 2024 Medicines Decision Summary - 30-day NICE TA953 - Mar 2024 Approved 28/03/2024
Medicines Decision Summary - 30-day NICE TA956 - March 2024 Medicines Decision Summary - 30-day NICE TA956 - Mar 2024 Approved 27/03/2024
Medicines Subcommittee decision summary February 2024 NENC Medicines Committee decision summary - February 2024 - final v2.1 Approved 12/02/2024
Medicines Subcommittee decision summary December 2023 Medicines Committee decision summary - December 2023 Approved 07/12/2023
Medicines Committee decision - NICE TA 929 - Empagliflozin for treating chronic heart failure with preserved or mildly reduced ejection fraction Medicines Committee decision - NICE TA 929 - Empagliflozin for treating chronic heart failure with preserved or mildly reduced ejection fraction Approved 20/11/2023
Medicines Committee Decision Summary - NICE TA918, TA920, TA925, TA927 - Nov 2023 Medicines Committee decision - NICE TA918, TA920, TA925, TA927 - Nov 2023 Approved 15/11/2023
Medicines Subcommittee decision summary October 2023 Medicines Committee decision summary - October 2023 v2 Approved 14/11/2023
Medicines Decision Summary - 30-day NICE TA916 - Oct 2023 Medicines Committee decision - NICE TA 916 - Bimekizumab PsA Approved 19/10/2023
Medicines Subcommittee decision summary September 2023 Medicines Committee decision summary - September 2023 - FNL Approved 02/10/2023
Medicines Subcommittee decision summary June 2023 Medicines Committee decision summary Jun 2023 - FNL Approved 20/06/2023
Medicines Subcommittee decision summary April 2023 Medicines Committee decision summary April 23 approved by ICB director 180523 Approved 18/05/2023
Medicines Decision Summary from March 2023 NENC ICB Executive Committee Medicines Decision Summary from March 2023 NENC ICB Executive Committee - final without VBC updates Approved 14/03/2023
Medicines Decision Summary - 30-day NICE TA861 - Feb 2023 Medicines Decision Summary - 30-day NICE TA861 - Feb 2023 Approved 14/03/2023
Medicines Decision Summary from January 2023 NENC ICB Executive Committee Medicines Decision Summary from January 2023 NENC ICB Executive Committee - final Approved 10/01/2023
Medicines Decision Summary from December 2022 NENC ICB Executive Committee Medicines Decision Summary from December 2022 NENC ICB Executive Committee - final Approved 13/12/2022